Skip to main content

Table 3 Multivariate logistic regression analyses of prolonged QTc interval and associated factors

From: Prevalence and risk factors of prolonged corrected QT interval in general Chinese population

Variables

ORs

95% CIs

P-value

Age (per 10 year increase)

1.228

1.168–1.290

< 0.001*

Female gender

2.878

2.564–3.229

< 0.001*

Race of Hana

1.196

0.981–1.458

0.076

Current smoking status

1.075

0.970–1.191

0.166

Current drinking status

0.938

0.821–1.071

0.344

Education

 Primary school or below

1.000 (reference)

 Middle school

1.075

0.974–1.186

0.151

 High school or above

1.157

0.986–1.357

0.073

Physical activity

 Low

1.000 (reference)

 Moderate

0.925

0.840–1.018

0.11

 High

0.832

0.685–1.011

0.064

Family income (CNY/year)

  ≤ 5000

1.000 (reference)

 5000–20,000

0.931

0.815–1.064

0.294

  > 20,000

0.926

0.799–1.072

0.302

General obesity

1.043

0.916–1.187

0.528

Abdominal obesity

1.156

1.010–1.324

0.035*

Hypertension

1.838

1.675–2.016

< 0.001*

Diabetes

1.593

1.391–1.824

< 0.001*

High TC

0.977

0.847–1.127

0.747

High TG

1.241

1.104–1.395

0.001*

High LDL-C

1.112

0.919–1.347

0.276

Low HDL-C

1.119

0.980–1.278

0.096

Calcium (mmol/L) < 1.875

0.667

0.178–2.497

0.547

Potassium (mmol/L) < 3.5

2.636

1.806–3.846

< 0.001*

Magnesium (mmol/L) < 0.7

0.746

0.200–2.789

0.664

History of heart diseaseb

1.065

0.927–1.223

0.375

Medication usedc

1.131

1.036–1.234

0.006*

  1. *P < 0.05 for the independent association between prolonged QTc interval and each factor after adjusting for the remaining factors
  2. Abbreviations: CNY, China Yuan (1CNY = 0.15 USD); HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; OR, odds ratio; QTc, corrected QT; 95% CI, 95% confidence interval
  3. aCompared with other ethnic minorities in China, such as Mongol and Manchu
  4. bIncluding coronary heart disease, arrythmia and heart failure
  5. cIndicating any self-reported medication used in the past two weeks